Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations

E Boerwinkle, S Brown, A R Sharrett, G Heiss, W Patsch, E Boerwinkle, S Brown, A R Sharrett, G Heiss, W Patsch

Abstract

To quantify the effect of the apolipoprotein (apo) E polymorphism on the magnitude of postprandial lipemia, we have defined its role in determining the response to a single high-fat meal in a large sample of (N = 474) individuals taking part in the biethnic Atherosclerosis Risk in Communities Study. The profile of postprandial response in plasma was monitored over 8 h by triglyceride, triglyceride-rich lipoprotein (TGRL)-triglyceride, apo B-48/apo B-100 ratio, and retinyl palmitate concentrations, and the apo E polymorphism was determined by DNA amplification and digestion. The frequency of the apo E alleles and their effects on fasting lipid levels in this sample were similar to those reported elsewhere. Postprandial plasma retinyl palmitate response to a high-fat meal with vitamin A was significantly different among apo E genotypes, with delayed clearance in individuals with an epsilon 2 allele, compared with epsilon 3/3 and epsilon 3/4 individuals. In the sample of 397 Caucasians, average retinyl palmitate response was 1,489 micrograms/dl in epsilon 2/3 individuals, compared with 1,037 micrograms/dl in epsilon 3/3 individuals and 1,108 micrograms/dl in epsilon 3/4 individuals. The apo E polymorphism accounted for 7.1% of the interindividual variation in postprandial retinyl palmitate response, a contribution proportionally greater than its well-known effect on fasting LDL-cholesterol. However, despite this effect on postprandial retinyl palmitate, the profile of postprandial triglyceride response was not significantly different among apo E genotypes. The profile of postprandial response was consistent between the sample of Caucasians and a smaller sample of black subjects. While these data indicate that the removal of remnant particles from circulation is delayed in subjects with the epsilon 2/3 genotype, there is no reported evidence that the epsilon 2 allele predisposes to coronary artery disease (CAD). The results of this study provide not only a reliable estimate of the magnitude of the effect of the apo E polymorphism on various measurements commonly used to characterize postprandial lipemia, but also provide mechanistic insight into the effects of the apo E gene polymorphism on postprandial lipemia and CAD.

References

    1. Arterioscler Thromb. 1991 Mar-Apr;11(2):221-33
    1. Clin Chem. 1986 May;32(5):778-81
    1. Arterioscler Thromb. 1991 May-Jun;11(3):653-62
    1. Am J Hum Genet. 1991 Aug;49(2):338-49
    1. Arterioscler Thromb. 1991 Sep-Oct;11(5):1237-44
    1. Arterioscler Thromb. 1991 Nov-Dec;11(6):1737-44
    1. Artery. 1991;18(6):315-25
    1. Stroke. 1992 Jun;23(6):823-8
    1. J Lipid Res. 1992 Jun;33(6):915-30
    1. Genet Epidemiol. 1992;9(3):155-67
    1. J Lipid Res. 1992 Apr;33(4):447-54
    1. J Neuroimaging. 1991 May;1(2):68-73
    1. Arterioscler Thromb. 1992 Nov;12(11):1336-45
    1. Am J Epidemiol. 1992 Sep 1;136(5):538-45
    1. Am J Epidemiol. 1992 Sep 1;136(5):546-57
    1. J Clin Invest. 1993 Feb;91(2):448-55
    1. J Clin Invest. 1964 May;43:943-9
    1. J Lab Clin Med. 1970 Feb;75(2):264-74
    1. Nature. 1970 Aug 15;227(5259):680-5
    1. J Clin Invest. 1974 May;53(5):1458-67
    1. Metabolism. 1976 JUL;25(7):777-801
    1. J Biol Chem. 1978 Sep 10;253(17):6289-95
    1. Circulation. 1979 Sep;60(3):473-85
    1. J Lipid Res. 1986 Apr;27(4):361-7
    1. J Clin Invest. 1986 Sep;78(3):815-21
    1. J Lipid Res. 1987 Apr;28(4):361-70
    1. J Clin Invest. 1987 Aug;80(2):341-7
    1. J Clin Invest. 1987 Aug;80(2):578-81
    1. Am J Hum Genet. 1988 Jan;42(1):104-12
    1. Science. 1988 Jan 29;239(4839):487-91
    1. Clin Genet. 1988 Jul;34(1):1-6
    1. J Lipid Res. 1988 Jul;29(7):925-36
    1. J Biol Chem. 1988 Sep 25;263(27):13880-90
    1. J Clin Invest. 1988 Nov;82(5):1633-43
    1. Clin Chem. 1989 Feb;35(2):265-70
    1. Genomics. 1988 Nov;3(4):373-9
    1. Am J Hum Genet. 1989 Nov;45(5):793-802
    1. Genet Epidemiol. 1989;6(6):681-9
    1. J Clin Invest. 1990 Mar;85(3):883-92
    1. J Lipid Res. 1990 Mar;31(3):545-8
    1. N Engl J Med. 1990 Nov 1;323(18):1234-8
    1. Arterioscler Thromb. 1991 Jan-Feb;11(1):2-14
    1. Biochim Biophys Acta. 1981 Jan 26;663(1):336-49
    1. J Biol Chem. 1981 Sep 10;256(17):9077-83
    1. J Clin Invest. 1981 Oct;68(4):1075-85
    1. J Biol Chem. 1982 Mar 10;257(5):2518-21
    1. Clin Chem. 1982 Jun;28(6):1379-88
    1. J Clin Invest. 1982 Aug;70(2):474-7
    1. J Lipid Res. 1982 Jul;23(5):702-14
    1. Arteriosclerosis. 1982 Nov-Dec;2(6):493-9
    1. Arteriosclerosis. 1983 Mar-Apr;3(2):170-7
    1. Arteriosclerosis. 1983 Jul-Aug;3(4):310-5
    1. Annu Rev Biochem. 1983;52:223-61
    1. Arteriosclerosis. 1984 Jan-Feb;4(1):49-58
    1. J Biol Chem. 1984 Jan 25;259(2):860-9
    1. Am J Clin Nutr. 1984 Feb;39(2):315-9
    1. Hum Genet. 1984;65(3):232-6
    1. Clin Genet. 1984 Apr;25(4):310-3
    1. Proc Natl Acad Sci U S A. 1984 Sep;81(17):5566-70
    1. J Lipid Res. 1984 Aug;25(8):805-12
    1. J Clin Invest. 1984 Dec;74(6):2017-23
    1. J Lipid Res. 1985 Aug;26(8):955-63
    1. J Lipid Res. 1990 Oct;31(10):1761-9

Source: PubMed

3
Abonnieren